Results 171 to 180 of about 1,916 (204)
Some of the next articles are maybe not open access.

Spectrophotometric Method for Determining Glyoxalase 1 Activity in Cerebral Cavernous Malformation (CCM) Disease

2020
Glyoxalase 1 (Glo1) is a glutathione (GSH)-dependent enzyme that catalyzes the isomerization of the hemithioacetal formed non-enzymatically from methylglyoxal (MG) and GSH to S-D-lactoylglutathione (SLG). The activity of Glo1 is measured spectrophotometrically by following the increase of absorbance at 240 nm and 25 °C, attributable to the formation of
Antognelli C., Talesa V. N., Retta S. F.
openaire   +4 more sources

Untreated cerebral cavernous malformations (CCM) – quality of life in one-year longitudinal follow up

2021
Objective: To estimate quality of life (QoL) during the natural course of patients with untreated cerebral cavernous malformations (CCM) using a one-year longitudinal follow up. Methods: 246 consecutive cases of CCM were included in a prospective longitudinal study assessing QoL and neurological/psychiatric[for full text, please go to the a.m. URL]
Herten, A   +9 more
openaire   +2 more sources

Next Generation Sequencing (NGS) Strategies for Genetic Testing of Cerebral Cavernous Malformation (CCM) Disease

2020
The application of next generation sequencing (NGS) technique has a great impact on complex disease studies. Indeed, genetic heterogeneity, phenotypic variability, and disease rarity are all factors that make the traditional diagnostic approach to genetic disorders, whereby a specific gene is selected for sequencing based on the clinical phenotype ...
Benedetti V.   +4 more
openaire   +2 more sources

Cerebral cavernous malformations (CCM) – the second symptomatic haemorrhage – long-term follow-up

2019
Objective: Risk for recurrent symptomatic hemorrhage in CCM is an important factor in decision making/consultation of patients. In this report, we analyze the risk and time pattern of re-hemorrhage events after a first initial bleeding. Methods: We performed a cross-sectional study based on[for full text, please go to the a.m. URL]
Rauscher, S   +6 more
openaire   +2 more sources

Study of the DNA promoter methylation of CCM genes in human cerebral cavernous malformation

2019
Objective: CCM is the second most common cerebrovascular disease and is classified as familial (20%) and sporadic (80%) forms. Loss of function mutation of three CCM genes can cause the familial CCM. However, the mechanism causing sporadic CCM remains unclear. Considering the DNA promoter [for full text, please go to the a.m. URL]
Saban, DV   +5 more
openaire   +1 more source

From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease

2020
Cerebral cavernous malformation (CCM) is a rare cerebrovascular disorder of genetic origin consisting of closely clustered, abnormally dilated and leaky capillaries (CCM lesions), which occur predominantly in the central nervous system. CCM lesions can be single or multiple and may result in severe clinical symptoms, including focal neurological ...
Retta S. F.   +3 more
openaire   +4 more sources

Pitfalls of conservative treatments of multiple probable cerebral cavernous malformations (CCMs): clinicopathological features of CCMs coexisting with vasculogenic mimicry in an anaplastic oligodendroglioma

Brain Tumor Pathology, 2013
Developments in magnetic resonance imaging (MRI) techniques have dramatically increased the detection of cerebral cavernous malformations (CCMs). Conservative treatment is often recommended for asymptomatic cases. However, CCMs occasionally harbor malignant gliomas.
Junkoh, Yamamoto   +3 more
openaire   +2 more sources

Cerebral cavernous malformation (CCM) disease: from monogenic forms to genetic susceptibility factors.

Journal of neurosurgical sciences, 2015
Cerebral cavernous malformation (CCM) is a vascular disease of proven genetic origin, which may arise sporadically or can be inherited as autosomal dominant condition with incomplete penetrance and highly variable expressivity. CCM lesions manifest across a range of different phenotypes, including wide interindividual differences in lesion number, size
TRAPANI, ELIANA   +1 more
openaire   +2 more sources

Cerebral cavernous malformation (CCM) – experience of a specialised cavernoma outpatient clinic with more than 1000 cases

2019
70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Skandinavischen Gesellschaft für ...
Dammann, P   +6 more
openaire   +2 more sources

Altered redox signaling and oxidative stress: the emerging faces of Cerebral Cavernous Malformation (CCM) pathogenesis

Free Radical Biology and Medicine, 2016
Cerebral Cavernous Malformation (CCM) is a major cerebrovascular disease of genetic origin affecting 0.3-0.5% of the population and characterized by abnormally enlarged and leaky capillaries that predispose to seizures, neurological deficits and intracerebral hemorrhage.
openaire   +2 more sources

Home - About - Disclaimer - Privacy